“Certain kinds of cancer are being diagnosed more often in younger adults in the US, a new study shows, and the increases seem to be driven by cancers in women and adults in their 30s.
A government-funded study of 17 National Cancer Institute registries, published Wednesday in the journal JAMA Network Open, looked at more than 500,000 cases of early-onset cancer, or cancers diagnosed in patients under age 50, between 2010 and 2019. The study found that overall, early-onset cancers increased over that decade, by an average of 0.28% each year.
Cancers with the highest numbers of early-onset cases diagnosed in 2019 were breast (12,649 cases), thyroid (5,869) and colorectal cancers (4,097).
The biggest increases in early-onset cases were in cancers of the appendix, which went up 252%; cancers of the bile duct, which went up 142%; and uterine cancer, which increased 76%.
Incidence rates of early-onset cancers of the gastrointestinal tract grew the fastest from 2010 to 2019, increasing nearly 15%. Previous research has shown a rise in cancers of the digestive system, particularly colorectal cancers, among adults younger than 55 since the 1990s. “ ( August 16, 2023)
So the incidence of certain cancers has increased—what is your point? You made the claim in your first comment that “Pharmaceutical companies have been enriched while the rates of many types of cancers have risen.” That’s non sequitur and your word choices imply that pharma companies are somehow at fault for this.